XML 45 R33.htm IDEA: XBRL DOCUMENT v3.25.2
Basis of Presentation and Significant Accounting Policies - Schedule of Revenues consist of product sales to customers (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Disaggregation of Revenue [Line Items]        
Total revenues $ 264,566 $ 241,963 $ 508,882 $ 447,794
NUPLAZID        
Disaggregation of Revenue [Line Items]        
Total revenues 168,479 157,409 328,199 287,332
DAYBUE        
Disaggregation of Revenue [Line Items]        
Total revenues $ 96,087 $ 84,554 $ 180,683 $ 160,462